(Q43133919)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20222099%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

title

Design and in vitro evaluation of branched peptide conjugates: turning nonspecific cytotoxic drugs into tumor-selective agents (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20222099%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20222099%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

Jlenia Brunetti

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20222099%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

Stefano Menichetti

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20222099%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

Alessandro Pini

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20222099%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

Luisa Bracci

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20222099%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

author name string

Chiara Pagliuca

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20222099%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

Lucia Vitellozzi

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20222099%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

Barbara Lelli

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20222099%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

publication date

1 April 2010

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20222099%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20222099%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

volume

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20222099%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20222099%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

page(s)

567-574

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20222099%20AND%20SRC:MED&resulttype=core&format=json

Peptide receptors as molecular targets for cancer diagnosis and therapy

19 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200900527

7 January 2021

Synthetic peptides in the form of dendrimers become resistant to protease activity

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200900527

7 January 2021

Stable peptide inhibitors prevent binding of lethal and oedema factors to protective antigen and neutralize anthrax toxin in vivo

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200900527

7 January 2021

Antimicrobial activity of novel dendrimeric peptides obtained by phage display selection and rational modification

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200900527

7 January 2021

Molecular basis of branched peptides resistance to enzyme proteolysis

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200900527

7 January 2021

Synthesis and biological activity of stable branched neurotensin peptides for tumor targeting

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200900527

7 January 2021

Oligo-branched peptides for tumor targeting: from magic bullets to magic forks

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200900527

7 January 2021

Branched peptides as therapeutics

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200900527

7 January 2021

Mechanism of inhibition of human KSP by ispinesib

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200900527

7 January 2021

Mechanism of inhibition of human KSP by monastrol: insights from kinetic analysis and the effect of ionic strength on KSP inhibition

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200900527

7 January 2021

Inhibition of a mitotic motor protein: where, how, and conformational consequences

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200900527

7 January 2021

Novel sulfonate analogues of combretastatin A-4: potent antimitotic agents

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200900527

7 January 2021

Combretastatin A4-induced differential cytotoxicity and reduced metastatic ability by inhibition of AKT function in human gastric cancer cells

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200900527

7 January 2021

Development of water soluble derivatives of cis-3, 4', 5-trimethoxy-3'-aminostilbene for optimization and use in cancer therapy.

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200900527

7 January 2021

The thiopurines: an update

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200900527

7 January 2021

Novel derivatives of 6-mercaptopurine: synthesis, characterization and antiproliferative activities of S-allylthio-mercaptopurines

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200900527

7 January 2021

Improved synthesis and preparative scale resolution of racemic monastrol

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200900527

7 January 2021

Antineoplastic agents. 291. Isolation and synthesis of combretastatins A-4, A-5, and A-6(1a)

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200900527

7 January 2021

Internalization-dependent regulation of HT29 cell proliferation by neurotensin.

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200900527

7 January 2021

Neurotensin receptor expression in prostate cancer cell line and growth effect of NT at physiological concentrations

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200900527

7 January 2021

Targeting HER2-positive breast cancer with trastuzumab-DM1, an antibody-cytotoxic drug conjugate

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200900527

7 January 2021

Identifiers

DOI

10.1002/CMDC.200900527

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20222099%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

1 reference